Ginkgo Bioworks Holdings (DNA) EBT Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
Ginkgo Bioworks Holdings (DNA) EBT Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | -115.00 |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 80.00 |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | -450.00 |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | -162.00 |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 5,201.00 |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | - |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | -14,710.00 |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 51.00 |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -2.77 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -751,066.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -14,710.00 |
| Mar 31, 2026 | -17,329.00 |
| Dec 31, 2025 | 227.00 |
| Sep 30, 2025 | -14,417.00 |
| Jun 30, 2025 | 24,941.00 |
| Mar 31, 2025 | 21,948.00 |
| Dec 31, 2024 | -15,882.00 |
| Sep 30, 2024 | 48,272.00 |
| Jun 30, 2024 | -17,103.00 |
| Mar 31, 2024 | -18,329.00 |
| Dec 31, 2023 | 10,396.00 |
| Sep 30, 2023 | 46,283.00 |
| Jun 30, 2023 | 24,868.00 |
| Mar 31, 2023 | 9,811.00 |
| Dec 31, 2022 | 89,018.00 |
| Sep 30, 2022 | -87,709.00 |
| Jun 30, 2022 | -33,791.00 |
| Mar 31, 2022 | -18,206.00 |
| Dec 31, 2021 | -93,660.00 |
| Sep 30, 2021 | 6,415.00 |